
Stand in the supplements section of any German pharmacy or health food store and count the forms of magnesium on the shelf. Glycinate. Citrate. Oxide. Threonate. Malate. Taurate. Chloride. Orotate. Bisglycinate. Each label with a different claim. Glycinate for sleep. Threonate for the brain. Citrate for digestion. Malate for energy. Oxide for everything, because it's the cheapest.
Here is the problem: most Europeans are genuinely, measurably low in magnesium. A cross-sectional study of more than 16,000 individuals in Germany found that 14.5% had frank hypomagnesaemia, and that figure almost certainly understates the real picture, because serum magnesium is a notoriously poor indicator of what's actually stored in your tissues. The actual prevalence of functional magnesium insufficiency in Germany is likely two to three times higher. [1]
That makes magnesium one of the few supplements where the case for supplementing is genuinely strong for a broad population. The catch is that buying the wrong form is substantially less effective than buying the right one, and the wrong form is very often magnesium oxide, which also happens to be the most widely sold. And buying the right one for the wrong goal is throwing money at a problem you may not have.
This article cuts through the marketing. Here is what each form actually does, what the evidence supports, and why the relationship between magnesium, vitamin D, and calcium means you can't sensibly optimise one without looking at all three.
Magnesium is a cofactor in more than 300 enzymatic reactions. That number appears in almost every magnesium article, and it's usually followed by a vague list of benefits such as energy, muscle function, and nerves, which doesn't help you understand what deficiency actually feels like. So here is a more concrete version.
Magnesium is required for every reaction that involves ATP, the molecule your cells use as their fundamental energy currency. No magnesium, no efficient ATP synthesis. Magnesium is also required to activate vitamin D; supplementing D3 without adequate magnesium means the conversion to its active hormonal form is impaired. It regulates calcium channels in muscle cells, which is why muscle cramps and twitching are among the first signs of depletion. It stabilises the electrical activity of the heart. It plays a central role in insulin signalling, and magnesium deficiency has been found in 14 to 48% of patients with type 2 diabetes, compared with 2.5 to 15% of the general population. [2]
Symptoms of suboptimal magnesium status include muscle cramps, fatigue, poor sleep quality, headaches, anxiety, and palpitations, which also happen to be the most common non-specific complaints in primary care. That overlap is not a coincidence.
In Germany, average dietary magnesium intake is approximately 200 mg per day for women and 250 mg per day for men. [1] The European Food Safety Authority recommends 300 mg daily for women and 350 mg for men. That gap, 100 mg or more, is not trivial. Chronic insufficiency at that level, sustained over years, has downstream consequences across cardiovascular, metabolic, and neurological function.
The underlying reasons are structural: magnesium is found primarily in dark leafy greens, legumes, nuts, seeds, and whole grains. Modern European diets, high in processed foods and refined carbohydrates, are structurally low in all of these. Beyond that, soil depletion means even whole foods contain less magnesium than they did decades ago. And several widely prescribed medications directly deplete magnesium stores: proton pump inhibitors (PPIs), diuretics, and metformin are among the most common offenders.
Globally, an estimated 2.4 billion people, roughly 31% of the world's population, fail to meet recommended magnesium intake levels. [3] Europe is not an exception.
Less than 1% of total body magnesium is found in the blood. The other 99% is distributed between bone (roughly 60%) and soft tissues including muscle (roughly 39%). [4]
Your body prioritises maintaining blood magnesium within a narrow range, and it will raid bone and muscle stores to do so. Which means a "normal" serum result of, say, 0.80 mmol/L tells you almost nothing reliable about what's happening in your tissues. You can be functionally depleted in muscle and bone while your blood result looks fine. A 2010 paper in Clinical Chemistry warned explicitly that "a health warning is needed for 'normal' serum magnesium results" precisely because clinicians routinely misinterpret them as exclusions of deficiency. [5]
Serum magnesium is not worthless. Very low levels are clinically significant, and it is the standard accessible measure. But interpreting it properly requires context. A serum result paired with calcium and vitamin D status gives a much richer picture: because these three minerals interact directly in absorption and metabolism, an imbalance between them can tell you more than any single value in isolation. The pattern matters more than any single number.
Aniva includes serum magnesium as part of a broader mineral and nutrient panel, reported alongside calcium and vitamin D, precisely because the story only makes sense when you read all three together. Understanding whether your magnesium level is genuinely adequate, borderline, or part of a wider mineral imbalance is the kind of context you rarely get from a standalone test. See the full biomarker panel →
The core distinction to understand before reading anything else: organic magnesium salts (citrate, glycinate, malate, threonate, taurate) are bound to organic molecules. They are generally more soluble in the gut and therefore better absorbed. Inorganic salts (oxide, sulphate, carbonate, chloride) are bound to inorganic compounds. They contain more elemental magnesium per gram but release it less efficiently. Higher elemental content does not equal higher absorption. The two are inversely related in practice.
This is what most people are taking, because it is what most pharmacy products and cheap supplements contain. Magnesium oxide has the highest elemental magnesium content per gram (about 60%), which is why it can label a capsule as "500 mg magnesium" at a fraction of the cost of other forms. The problem is bioavailability. In direct comparison studies, magnesium oxide shows substantially lower fractional absorption than organic forms. [6] A randomised double-blind study published in Magnesium Research found magnesium citrate to be significantly more bioavailable than oxide. [7]
The practical takeaway: if you are taking magnesium oxide and not noticing much effect, the form is likely the problem, not the dose.
One of the most well-studied and bioavailable forms. Citrate dissolves readily in the gut and shows consistent absorption advantage over oxide in head-to-head comparisons. It is the form recommended by the Canadian Headache Society for migraine prophylaxis at 600 mg daily, the single use case where the evidence for magnesium supplementation is strongest. [8]
The caveat: magnesium citrate has a mild osmotic laxative effect at higher doses. At 200 to 400 mg, most people tolerate it well. At 600 mg or more, loose stools are common. This is not a safety concern but does matter for comfort and adherence.
Magnesium glycinate binds one magnesium ion to the amino acid glycine. Bisglycinate binds two. In practice, the terms are used interchangeably in most contexts, and both are among the most well-tolerated forms: minimal gastrointestinal side effects, no laxative effect, and high bioavailability. Glycine itself has mild relaxing properties, which has contributed to the strong association between this form and sleep benefits.
This association now has direct RCT support. A 2025 randomised, double-blind, placebo-controlled trial enrolling 155 adults with self-reported poor sleep quality found that 250 mg elemental magnesium as bisglycinate produced a significantly greater reduction in Insomnia Severity Index scores versus placebo after four weeks (-3.9 vs -2.3, p = 0.049). [9] For people who want to supplement magnesium primarily for sleep or anxiety, this is currently the most practically supported form.
Threonate is a newer, patented form developed specifically for its ability to cross the blood-brain barrier and raise brain magnesium concentrations. This distinguishes it mechanistically from all other forms, which raise systemic magnesium but have limited direct CNS penetration. A 2024 randomised controlled trial found that magnesium L-threonate improved sleep quality and daytime cognitive function in adults with self-reported sleep problems. [10]
The important caveats: threonate contains significantly less elemental magnesium per gram than other forms, meaning it is poorly suited to correcting systemic deficiency. It is also considerably more expensive. If your goal is raising brain magnesium for cognitive or sleep endpoints specifically, the evidence is interesting but still early. If your goal is correcting a general magnesium deficit, citrate or glycinate will serve you better at a fraction of the cost.
Malate is bound to malic acid, a compound involved in the Krebs cycle, the cell's core energy production pathway. This has generated claims that magnesium malate supports energy metabolism and reduces fatigue, and there is some mechanistic logic to that. It is also the most commonly studied form in fibromyalgia, where combined magnesium and malate supplementation has shown modest improvements in pain and fatigue in small trials.
For general supplementation purposes, malate is a reasonable organic option. The specific energy-pathway claims are plausible but not strongly confirmed in healthy populations.
Taurate combines magnesium with taurine, an amino acid with proposed cardiovascular-protective effects. There is a reasonable theoretical case for cardiovascular applications such as supporting blood pressure, cardiac rhythm, and endothelial function. Direct human evidence specifically attributing cardiovascular benefits to the taurate form (rather than to magnesium repletion generally) remains thin. It is safe and well-tolerated, but not a clear first choice for any specific application over glycinate or citrate.
Chloride is a highly soluble inorganic salt with good oral bioavailability, better than oxide, though typically below the organic forms. It is also available in topical form (sprays, flakes, bath salts), which has generated significant interest as "transdermal magnesium therapy." The evidence for meaningful transdermal absorption through intact skin remains weak; most dermatological research suggests that the skin is an effective barrier to ion transport. Oral chloride is a reasonable choice; transdermal claims are largely unsupported.
Intravenous magnesium sulphate has a well-established clinical role: eclampsia prevention in pregnancy, acute severe asthma, and torsades de pointes (a dangerous arrhythmia). The same scepticism that applies to transdermal chloride applies here. Soaking in an Epsom salt bath may be relaxing, which is not nothing, but the claim that significant magnesium is absorbed through skin during a bath is not convincingly supported by the current evidence.
Carbonate has a role as an antacid and short-term remedy for heartburn. Its solubility is modest and its bioavailability for systemic supplementation is lower than the organic forms. Long-term use can cause digestive discomfort. Not a first choice for deficiency correction.
Orotate is sometimes marketed as a premium form with cardiac benefits, based on the role of orotic acid in cellular energy metabolism. Some cardiological studies have used it in specific clinical populations. For general supplementation, the evidence base does not justify the significantly higher price point over citrate or glycinate.
The sleep claim for magnesium is the most widely marketed and, in fairness, has the most direct evidence behind it. A 2024 systematic review of the available literature found that five out of eight sleep-related studies reported improvements in sleep parameters with magnesium supplementation. [11] A 2021 meta-analysis pooling three RCTs in 151 older adults found that sleep onset latency was reduced by 17.36 minutes compared to placebo (95% CI -27.27 to -7.44, p = 0.0006). [12]
The honest qualifier: the evidence is rated as "low to very low quality" by the reviewers, not because it's negative, but because the trials are small and heterogeneous. The sleep benefit appears most robust in people with magnesium insufficiency at baseline. Someone with genuinely low magnesium who supplements with glycinate or bisglycinate has good reason to expect sleep improvement. Someone with adequate magnesium levels spending €60 per month on magnesium threonate for its "sleep benefits" should temper expectations.
This is the single strongest evidence base for magnesium supplementation in any specific condition. Multiple double-blind placebo-controlled RCTs support magnesium citrate at 600 mg daily for migraine prophylaxis. A landmark 1996 multi-centre trial showed that attack frequency was reduced by 41.6% in the magnesium group versus 15.8% in placebo over weeks 9 to 12 (p < 0.05). [13] European headache guidelines list magnesium as a second-line prophylactic agent across multiple national frameworks. If you have frequent migraines, this is one case where magnesium supplementation is genuinely clinically rational, not just wellness-adjacent.
The 2024 systematic review by Rawji et al. found that five of seven anxiety-related studies showed improvements with magnesium supplementation. The picture is complicated by heterogeneous study populations and varying baseline magnesium status. The evidence is most consistent in people with identified deficiency. For people with low-normal magnesium who report persistent anxiety or stress, supplementation is reasonable and the safety profile is excellent.
Epidemiological evidence consistently shows an inverse relationship between magnesium intake and type 2 diabetes risk. The mechanism is sound: magnesium is required for insulin receptor signalling and for glucose transporter function. Magnesium deficiency has been documented in 14 to 48% of people with type 2 diabetes. [2] Supplementation in deficient individuals with pre-diabetes or T2D has shown improvements in insulin sensitivity in several RCTs.
The honest framing: magnesium is not a metabolic intervention in people with adequate levels. But for the significant proportion of European adults who are subtly deficient, particularly those carrying metabolic risk factors, restoring adequate status is part of the metabolic picture.
Low magnesium is an independent risk factor for hypertension, cardiac arrhythmias, and cardiovascular events. A 2018 review in Open Heart described subclinical magnesium deficiency as "a principal driver of cardiovascular disease and a public health crisis." [1] The evidence here is strongest for population-level deficiency as a risk factor, and less clear for supplementation benefits in people with already-adequate magnesium status. Restoring sufficiency matters; megadosing beyond sufficiency does not clearly add cardiovascular benefit.
Some risk factors make deficiency far more likely, such as taking a PPI or a diuretic, managing blood sugar, being female and in your 30s or 40s, or exercising heavily. If any of those apply, testing your magnesium level in context makes considerably more sense than guessing at a dose. A magnesium reading paired with calcium and vitamin D gives you the baseline to supplement precisely rather than arbitrarily. Get started with Aniva →
This is the aspect of magnesium supplementation that the wellness industry most consistently misses, and it matters enormously for anyone supplementing vitamin D, which is a significant proportion of the Northern European population.
Vitamin D is biologically inert until converted to its active hormonal form, calcitriol. That conversion process requires magnesium at multiple steps. Supplementing vitamin D without adequate magnesium may produce little to no functional benefit from the supplemented dose. There is emerging evidence that vitamin D supplementation in magnesium-deficient individuals can actually increase the risk of calcium dysregulation by raising inactive vitamin D metabolites without producing the corresponding active form. See our article on vitamin D in Northern Europe →
Magnesium and calcium also share intestinal absorption transporters and compete when either is taken in high doses. High-dose calcium supplementation without adequate magnesium is associated with an increased risk of soft tissue calcification, one of the risks that vitamin K2 is proposed to mitigate by directing calcium toward bone rather than arteries.
This is why the supplement industry's approach of selling each mineral in isolation, with one product for D, another for Mg, and another for calcium, fundamentally misrepresents how these nutrients actually function. They operate as a system. Optimising one without considering the others is managing one variable while ignoring the equation.
Certain groups face systematically higher risk of magnesium insufficiency, based on consistent evidence across population studies:
Women in their 30s and 40s, particularly those with high stress, irregular sleep, or irregular dietary patterns. The SHIP study found deficiency in 27.9% of women versus 21.9% of men in Germany.
People taking proton pump inhibitors (omeprazole, pantoprazole, and similar). PPIs directly reduce gastric acid, which impairs magnesium absorption. Long-term PPI use is an established cause of clinically significant hypomagnesaemia.
People taking diuretics or metformin. Both classes increase urinary magnesium excretion.
People managing blood sugar or type 2 diabetes. Insulin resistance and hyperglycaemia increase renal magnesium losses.
Endurance athletes and people training heavily. Magnesium is lost through sweat and its requirements increase with exercise-related metabolic demands.
Older adults. Intestinal absorption efficiency decreases with age; the elderly are consistently the highest-risk demographic across all European surveys.
For general deficiency correction: magnesium citrate (200 to 400 mg elemental magnesium daily) is the most practical choice. It has high bioavailability, it is widely available, and it is reasonably priced. Bisglycinate is the alternative for people who experience digestive sensitivity to citrate.
For sleep and anxiety: magnesium glycinate or bisglycinate, taken in the evening. The glycine component contributes to the relaxing effect. Evidence as of 2025 is the most direct for bisglycinate specifically.
For migraine prophylaxis: magnesium citrate at 600 mg daily. This is the clinically studied dose; European headache guidelines include magnesium at this dose as a second-line prophylactic option.
For cognitive or sleep-specific brain applications: magnesium L-threonate is the only form with evidence for CNS penetration. It is expensive and contains less elemental magnesium, so combine it with a standard form if systemic repletion is also needed.
For general supplementation when tolerability is the priority: bisglycinate. Least likely to cause GI side effects at any dose.
What to avoid unless you have a specific reason for it: magnesium oxide, which is the most widely sold form but substantially less bioavailable than the alternatives. The price advantage does not compensate for the absorption disadvantage.
Magnesium supplementation has a good safety profile. The kidneys efficiently excrete excess magnesium in people with normal kidney function, and the main side effect of over-supplementation is diarrhoea. The upper tolerable intake level set by the EFSA for supplemental magnesium is 250 mg per day from supplements (in addition to dietary sources). Many studies and clinical guidelines use 300 to 600 mg; the 250 mg figure reflects an abundance of caution rather than a hard toxicity threshold for healthy adults with normal renal function.
That said, the case for knowing your actual magnesium status before loading up on supplements is real. Most people who take magnesium do so because they read something online about sleep, or anxiety, or energy, not because they actually know whether they're deficient. For the significant proportion of the European population that genuinely is insufficient, the supplement makes sense. For those who aren't, the marginal benefit is unclear.
Aniva tests magnesium as part of a comprehensive mineral panel, including calcium and vitamin D, because these three markers are clinically meaningless without each other. For €199 per year, you get a complete baseline across 100+ biomarkers, tested at an ISO 15189-certified German laboratory, with a personalised report that contextualises each result rather than just flagging abnormal values. Start your membership →
Magnesium is not a wellness trend. It is an essential mineral involved in hundreds of biochemical reactions, chronically under-consumed across the European population, and poorly reflected by the standard serum test. The supplement industry has turned this genuine nutritional gap into an elaborate marketing matrix of ten forms and ten claims, in which each form appears to have a unique and essential purpose.
The reality is simpler. Most people who would benefit from magnesium supplementation would do well with magnesium citrate or glycinate, at 200 to 400 mg of elemental magnesium daily. The premium forms serve specific purposes, such as threonate for CNS penetration and bisglycinate for superior tolerability, but the fundamentals are not complicated.
What is complicated is knowing whether you need to supplement at all, and at what dose, without knowing your baseline status and how it relates to your calcium and vitamin D levels. That is the question a blood test answers, not a supplement label.
This content is for informational purposes only and is not medical advice. Always discuss results and supplementation choices with a qualified healthcare professional. Magnesium supplementation can interact with certain medications, including antibiotics, diuretics, and bisphosphonates. People with kidney disease should not supplement magnesium without medical supervision, as impaired renal function reduces the ability to excrete excess magnesium.
1. DiNicolantonio JJ, O'Keefe JH, Wilson W. "Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis." Open Heart. 2018;5(1):e000668. PMC
2. Jukić Kasap Ž, et al. "Magnesium: Health Effects, Deficiency Burden, and Future Public Health Directions." Nutrients. 2025;17(22):3626. MDPI
3. Sharifi-Zahabi E, et al. "Global Dietary Magnesium Deficiency: Prevalence, Underlying Causes, Health Consequences, and Strategic Solutions." IJVNR. 2025. IMRPRESS
4. Schwalfenberg GK, Genuis SJ. "The Importance of Magnesium in Clinical Healthcare." Nutrients. 2019;11(2):296. PMC
5. Costello R, Wallace TC, Rosanoff A. "The underestimated problem of using serum magnesium measurements to exclude magnesium deficiency in adults." Magnesium Research. 2010. PubMed
6. Henry C, et al. "Predicting and Testing Bioavailability of Magnesium Supplements." Nutrients. 2019;11(7):1663. PMC
7. Walker AF, Marakis G, Christie S, Byng M. "Magnesium citrate found more bioavailable than other Magnesium preparations in a randomised, double-blind study." Magnesium Research. 2003;16(3):183-191. PubMed
8. Teigen L, Boes CJ. "An evidence-based review of oral magnesium supplementation in the preventive treatment of migraine." Cephalalgia. 2015;35(10):912-922. Sage
9. Schuster J, et al. "Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial." Nutrients. 2025. PMC
10. Hausenblas HA, Lynch T, Hooper S, et al. "Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: a randomized controlled trial." Sleep Medicine X. 2024;8:100121. ScienceDirect
11. Rawji A, et al. "Examining the Effects of Supplemental Magnesium on Self-Reported Anxiety and Sleep Quality: A Systematic Review." Cureus. 2024;16(4):e59317. PubMed
12. Mah J, Pitre T. "Oral magnesium supplementation for insomnia in older adults: a Systematic Review and Meta-Analysis." BMC Complementary Medicine and Therapies. 2021;21(1):125. PMC
13. Peikert A, Wilimzig C, Köhne-Volland R. "Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study." Cephalalgia. 1996;16(4):257-263. Sage
14. Workinger JL, Doyle RP, Bortz J. "Challenges in the Diagnosis of Magnesium Status." Nutrients. 2018;10(9):1202. PMC